Press
Press inquiries: rick@belly-md.com. Interviews, demos, and early-user connections available on request.
News
An Emergency Physician's Answer to "Your Labs Are Normal": BellyMD Releases MeNome, an Instrument That Maps Each Person's Gut-Brain Pattern
PHILADELPHIA — BellyMD today announced the public availability of MeNome, an iOS app that maps the daily patterns of disorders of gut-brain interaction, the family of conditions that includes irritable bowel syndrome, functional dyspepsia, and cyclic vomiting syndrome. These disorders affect more than one in three people worldwide, yet standard bloodwork and imaging routinely come back normal, leaving patients cycling between specialists without answers.
MeNome was built by BellyMD founder and CEO Rick Pescatore, D.O., a board-certified emergency physician, around a premise drawn from thousands of emergency department visits: snapshot tests cannot see disorders that live in time. Gut-brain conditions unfold in the relationship between sleep, stress, meals, cycles, and symptoms, and a single blood draw or scope captures none of it. MeNome's daily check-in takes about a minute. Over two weeks it assembles each user's symptom fingerprint, a map of that person's specific patterns and suspected triggers, scored daily and built on the Rome criteria, the international diagnostic standard for these disorders. A BioScan feature reads the body's stress signal in thirty seconds using the phone's camera and microphone. The app is free to download, and everyone who joins during the free period keeps free access to the core experience for life. Results are exportable as a structured report a patient can hand to their physician. MeNome does not diagnose; it hands patients and their clinicians the data these conditions have always hidden.
"Every emergency physician knows the patient who has been sick for ten years and told for ten years that their labs are normal," said Pescatore. "The labs were never the right instrument. These disorders are patterns that unfold over time, and MeNome is an instrument built to read them."
BellyMD's research arm is applying the same conviction to cannabinoid hyperemesis syndrome (CHS), a severe cyclic vomiting illness in regular cannabis users that has grown with legalization and now presents in American emergency departments daily. CHS has no objective test; diagnosis today depends on recognition, and recognition routinely takes years and repeated emergency visits. BellyMD holds an exclusive option to license blood-biomarker technology developed at the George Washington University and is collaborating on research toward the first blood-based diagnostic for the condition. The work remains at the research stage.
Pescatore has led NIDA-funded programs supporting emergency physicians in substance-use disorder care since 2016 and has treated hundreds of CHS cases. "CHS is not rare. It is unrecognized," he said. "You cannot manage what you cannot measure. Nobody has been able to measure it."
BellyMD has been selected for NVIDIA Inception, AWS Activate, and Google for Startups, the startup programs of NVIDIA, Amazon, and Google.
MeNome is available on the App Store.
Fast facts
- The conditions: disorders of gut-brain interaction (DGBI) affect more than one in three people worldwide (Rome Foundation global epidemiology study). Standard labs and scopes are typically normal; diagnosis rests on symptom patterns over time.
- The app: MeNome, iOS, free to download. One-minute daily check-in; personal symptom map assembles over 14 days; thirty-second BioScan stress read; structured report exportable to a physician. Built on the Rome criteria framework. It does not diagnose, treat, or replace clinical care.
- The promise: everyone who joins while the app is free keeps free access to the core experience for life. Public and binding.
- The research: exclusive option on George Washington University blood-biomarker technology; research toward the first blood-based diagnostic for cannabinoid hyperemesis syndrome; a patent-pending investigational therapeutic program targeting DGBI.
- The company: BellyMD, Philadelphia. Family-built; no venture firm. Selected for NVIDIA Inception, AWS Activate, and Google for Startups. Published clinical advisory team spanning emergency medicine, analgesia, and gastroenterology.
About the founder
Rick Pescatore, D.O., is a board-certified emergency physician and the founder and CEO of BellyMD. He came up as an EMT in South Jersey, graduated with honors in aerospace engineering from the U.S. Naval Academy, and served as a nuclear submarine officer before medical school. He served as Chief Physician of Delaware's Division of Public Health during the COVID-19 pandemic, has led NIDA-funded programs supporting emergency physicians in substance-use disorder care since 2016, was the first emergency physician diplomate of the American Interventional Headache Society, is an author for the Merck Manual, and is editor-in-chief of Emergency Medicine News. He still works emergency department shifts. His medical content draws more than 15 million views a month across platforms.
Kady Pescatore, J.D., is co-founder and COO. Henrik Pitzner Liljegren is CTO.
Story lanes Dr. Pescatore can speak to
- Why "your labs are normal" is the most expensive sentence in gastroenterology
- Cannabinoid hyperemesis syndrome: the illness that surged with legalization, and why nobody can test for it
- What an aerospace engineer sees in a symptom diary: signal, noise, and time-series
- The gut-brain axis without the wellness industry attached
- Building clinical-grade tools outside the hospital system
Assets
Founder headshots, app screenshots, and logo files available on request at rick@belly-md.com.